No Data
No Data
Hims & Hers, LifeMD Shares Soar 20+% Amid Novo Nordisk Deal for Weight-Loss Drugs
Eli Lilly Stock Gets a Double Downgrade. Where Weight-Loss Drugs Go From Here. -- Barrons.com
Sector Update: Consumer Stocks Rise in Late Afternoon
Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum
Eli Lilly and Company's (NYSE:LLY) P/E Still Appears To Be Reasonable
WW International Partners With LillyDirect Pharmacy Provider to Support Members in Getting Zepbound Vials